Not quite what we thought...so the sale of shares between entities.
That would appear to be below the threshold for a significant shareholder.(MT Newswires) -- Jianmin Pharmaceutical Group (SHA:600976) will acquire a 4.47% stake in Australia-listed Hera Med (ASX:HMD) for 8.4 million yuan from Huali Pharmaceutical Group.
The Chinese drugmaker will buy 10.9 million shares in Hera Med, according to a filing on Wednesday.
Jianmin issued a risk warning about the transaction as it involves cross-border equity transfer, which could be subject to regulatory requirements.
Price (RMB): ¥49.04, Change: ¥-0.16, Percent Change: -0.33%
Jianmin Pharma, page-9
Add HMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.3¢ |
Change
-0.001(4.17%) |
Mkt cap ! $14.56M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.4¢ | 2.3¢ | $8.548K | 368.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 329404 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 142222 | 2 |
View Market Depth
| Last trade - 15.59pm 19/07/2024 (20 minute delay) ? |
| HMD (ASX) Chart |